Patents by Inventor Hannah White

Hannah White has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patient-specific medical devices and additive manufacturing processes for producing the same
    Patent number: 11960266
    Abstract: Systems and processes for designing and generating personalized surgical implants and devices are described herein. In various embodiments, the process includes generating patient-specific implants with patient-specific surface(s) and/or textures designed for increased osseointegration and improved surgical outcomes. In various embodiments, the process includes extracting patient-specific data with one or more aspects of an anatomical feature, processing the one or more aspects of the anatomical feature to create a non-rigid shape reference, and generating a patient-specific implant or device.
    Type: Grant
    Filed: August 23, 2023
    Date of Patent: April 16, 2024
    Assignee: RESTOR3D, INC.
    Inventors: Cambre Kelly, Hannah White
  • Synthesis of 1,4-diazaspiro[5.5]undecan-3-one
    Patent number: 11708337
    Abstract: This invention provides a process for preparing 1,4-diazaspiro[5.5]undecan-3-one and analogues thereof that are useful in the preparation of pharmaceutical compound, including for the treatment of disorders involving abnormal cellular proliferation. Chemical intermediates in the process are also provided.
    Type: Grant
    Filed: February 24, 2021
    Date of Patent: July 25, 2023
    Assignee: G1 Therapeutics, Inc.
    Inventors: Stephen E. Schneider, Hannah White, Thomas Fessard, Sagar Beldar
  • SYNTHESIS OF 1,4-DIAZASPIRO[5.5]UNDECAN-3-ONE
    Publication number: 20210179567
    Abstract: This invention provides a process for preparing 1,4-diazaspiro[5.5]undecan-3-one and analogues thereof that are useful in the preparation of pharmaceutical compound, including for the treatment of disorders involving abnormal cellular proliferation. Chemical intermediates in the process are also provided.
    Type: Application
    Filed: February 24, 2021
    Publication date: June 17, 2021
    Applicant: G1 Therapeutics, Inc.
    Inventors: Stephen E. Schneider, Hannah White, Thomas Fessard, Sagar Beldar